Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Get Free Report) saw a large drop in short interest in the month of August. As of August 31st, there was short interest totalling 958,600 shares, a drop of 27.4% from the August 15th total of 1,320,000 shares. Based on an average daily trading volume, of 413,400 shares, the short-interest […]
Eton Pharmaceuticals (NASDAQ:ETON – Get Free Report) and Planet 13 (OTCMKTS:PLNHF – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation. Profitability This table compares Eton Pharmaceuticals and Planet […]
Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Get Free Report) was the recipient of a significant increase in short interest in August. As of August 15th, there was short interest totalling 1,320,000 shares, an increase of 150.1% from the July 31st total of 527,700 shares. Currently, 5.9% of the shares of the stock are sold short. Based […]
Eton Pharmaceuticals (NASDAQ:ETON – Get Free Report) is set to release its earnings data after the market closes on Thursday, August 10th. Analysts expect Eton Pharmaceuticals to post earnings of ($0.09) per share for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link. Eton Pharmaceuticals […]
Eton Pharmaceuticals (NASDAQ:ETON – Free Report) had its price objective cut by HC Wainwright from $10.00 to $9.00 in a report released on Monday morning, FlyOnTheWall reports. HC Wainwright also issued estimates for Eton Pharmaceuticals’ FY2023 earnings at ($0.31) EPS, Q1 2024 earnings at ($0.03) EPS, Q2 2024 earnings at $0.02 EPS, Q3 2024 earnings […]